Adjuvant chemohormonal therapy with cyclophosphamide, methotrexate, 5-fluorouracil, and prednisone (CMFP) or CMFP plus tamoxifen compared with CMF for premenopausal breast cancer patients. An eastern cooperative oncology group trial

Nonparametric Estimation from Incomplete Observations

1992 • 45,923 citations

Nonparametric Estimation from Incomplete Observations

1958 • 37,219 citations

Toxicity and response criteria of the Eastern Cooperative Oncology Group

1982 • 10,605 citations

Nonparametrics: Statistical Methods Based on Ranks

1979 • 3,437 citations

Asymptotically Efficient Rank Invariant Test Procedures

1972 • 3,392 citations

Nonparametrics: Statistical Methods Based on Ranks.

1976 • 2,118 citations

Indices of relative weight and obesity

1972 • 1,967 citations

Statistical Methods for Research Workers.

1930 • 1,395 citations

Combination Chemotherapy as an Adjuvant Treatment in Operable Breast Cancer

1976 • 1,333 citations

L-Phenylalanine Mustard (L-PAM) in the Management of Primary Breast Cancer

1975 • 752 citations

The randomization and stratification of patients to clinical trials

1974 • 595 citations

Estimation of human body surface area from height and weight.

1970 • 566 citations

Cancer of the breast: Size of neoplasm and prognosis

1969 • 491 citations

Anti-oestrogen Therapy for Breast Cancer: A Trial of Tamoxifen at Two Dose Levels

1973 • 373 citations

Treatment of Primary Breast Cancer with Chemotherapy and Tamoxifen

1981 • 289 citations

Adjuvant CMF in breast cancer: comparative 5-year results of 12 versus 6 cycles.

1983 • 193 citations

Combination chemotherapy for metastatic breast carcinoma.Prospective comparison of multiple drug therapy with L-phenylalanine mustard

1976 • 173 citations

Comparison of induction chemotherapies for metastatic breast cancer. An eastern cooperative oncology group trial

1982 • 118 citations

Evaluation of tamoxifen dose in advanced breast cancer: a progress report.

1976 • 97 citations

A randomized trial of five and three drug chemotherapy and chemoimmunotherapy in women with operable node positive breast cancer.

1983 • 85 citations

Combination chemotherapy (CMFVP) versus L-phenylalanine mustard (L-PAM) for operable breast cancer with positive axillary nodes. A southwest oncology group study

1982 • 79 citations

Adjuvant treatment for early breast cancer: the Ludwig breast cancer studies.

1986 • 66 citations

Tamoxifen versus placebo: double-blind adjuvant trial in elderly women with stage II breast cancer.

1986 • 56 citations

Dibromodulcitol and Adriamycin ± tamoxifen in advanced breast cancer*

1982 • 55 citations

Adjuvant therapy of stage II breast cancer

1981 • 53 citations

Prospective evaluation of rotating chemotherapy in advanced breast cancer. An Eastern Cooperative Oncology Group Trial.

1983 • 51 citations

Postoperative chemotherapy and chemohormonal therapy in women with node-positive breast cancer.

1986 • 40 citations

Prospective evaluation of rotating chemotherapy in advanced breast cancer

1983 • 22 citations

Short term high density systemic therapy for metastatic breast cancer

1985 • 22 citations

Actual versus ideal weight in the calculation of surface area: effects on dose of 11 chemotherapy agents.

1987 • 18 citations

Relationship between time to treatment failure and survival and between time to response and response duration in metastatic breast cancer. Implications for treatment.

1981 • 10 citations

Adjuvant combination chemotherapy for operable breast cancer. Trials in progress at the Istituto Nazionale Tumori of Milan.

1981 • 10 citations

Deleted Work

1955 • 0 citations